The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
This article has 8 authors:Reviewed by ScreenIT
-
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology
This article has 14 authors:Reviewed by ScreenIT
-
Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
This article has 11 authors:Reviewed by ScreenIT
-
DNA spike-ins enable confident interpretation of SARS-CoV-2 genomic data from amplicon-based sequencing
This article has 19 authors:Reviewed by ScreenIT
-
SARS‐CoV‐2 show no infectivity at later stages in a prolonged COVID‐19 patient despite positivity in RNA testing
This article has 16 authors:Reviewed by ScreenIT
-
Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA
This article has 11 authors:Reviewed by ScreenIT
-
Control-theoretic immune tradeoffs explain SARS-CoV-2 virulence and transmission variation
This article has 5 authors:Reviewed by ScreenIT
-
Does Telemedicine Reduce health disparities? Longitudinal Evidence during the COVID-19 Pandemic in the US
This article has 2 authors:Reviewed by ScreenIT
-
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
This article has 20 authors:Reviewed by ScreenIT
-
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
This article has 13 authors:Reviewed by ScreenIT